Company Filing History:
Years Active: 1997
Title: The Innovative Contributions of Rosemary Rozman
Introduction
Rosemary Rozman is a notable inventor based in Flemington, NJ (US). She has made significant contributions to the field of pharmaceutical formulations, particularly in the development of stable formulations of 2-chloro-2'-deoxyadenosine (2-CdA). With a total of 2 patents, her work has the potential to impact medical treatments significantly.
Latest Patents
Rozman's latest patents include innovative formulations that enhance the stability of 2-CdA in water. The first patent discloses shelf-stable formulations containing benzyl alcohol and, optionally, propylene glycol. The second patent presents stable formulations that incorporate benzyl alcohol, m-cresol, a buffer, and sodium chloride or a solubilizing agent such as propylene glycol or polyethylene glycol. These advancements are crucial for improving the efficacy and shelf life of pharmaceutical products.
Career Highlights
Rosemary Rozman is currently associated with Ortho Pharmaceutical Corporation, where she continues to contribute to the field of pharmaceutical research and development. Her expertise in formulation science has positioned her as a valuable asset within her organization.
Collaborations
Throughout her career, Rozman has collaborated with esteemed colleagues, including Michael Bornstein and Kevin Francis Long. These partnerships have fostered an environment of innovation and have led to the successful development of her patented formulations.
Conclusion
In summary, Rosemary Rozman's contributions to pharmaceutical formulations, particularly her work on 2-chloro-2'-deoxyadenosine, highlight her innovative spirit and dedication to improving medical treatments. Her patents reflect a commitment to advancing the field and enhancing patient care.